Arif Hameed

Researcher

University of Arkansas for Medical Sciences

faculty

15 h-index 49 pubs 907 cited

Is this your profile? Verify and claim your profile

Biography and Research Information

OverviewAI-generated summary

Arif Hameed's research focuses on clinical outcomes in oncology and infectious diseases. He has investigated treatment outcomes for metastatic prostate adenocarcinoma, exploring the efficacy of abiraterone and enzalutamide. His work also addresses treatment outcomes in Stage II-III rectal cancer patients undergoing neoadjuvant therapy, with a comprehensive analysis of pathological findings. Hameed has also published on the host-pathogen interaction, specifically how lipolysis of host triacylglyceride-rich lipoproteins affects the microenvironment for *Staphylococcus aureus*. Additionally, his research has examined barriers to genetic testing adoption in oncology within Pakistan and a case study of a sequestrum perforating into the urinary bladder. His scholarly contributions include 49 publications, a citation count of 907, and an h-index of 15. He has collaborated with researchers at the University of Arkansas for Medical Sciences, including Mark S. Smeltzer, Karen E. Beenken, and C D Collins.

Metrics

  • h-index: 15
  • Publications: 49
  • Citations: 907

Selected Publications

  • Lipolysis of host triacylglyceride-rich lipoproteins creates a toxic microenvironment for <i>Staphylococcus aureus</i> (2026) DOI

Collaborators

Researchers in the database who share publications

Similar Researchers

Based on overlapping research topics